PharmAsia News

Australian CRO Novotech Expands Asian Footprint Into Southeast Asia Australia’s largest independent contract research organisation, Sydney-based Novotech, is expanding its operations into four new Asian markets and establishing a management hub in Kuala Lumpur, Malaysia. “In keeping with our continued expansion in Asia, we are rolling out operations across Southeast Asia in four countries: Singapore, [...]

CentreWatch: Clinical Trials Today

Novotech to Operate in Four More Asian Countries Continuing with its Asian growth plans, Australia-based contract research organization (CRO) Novotech http://www.novotech-cro.com is expanding its operations to include four more Asian countries: Malaysia, Singapore, Thailand and Philippines. Safarian is continuing with Novotech’s Asian expansion plans because of the noticeable shift in the number of trials he [...]

Outsourcing-Pharma.com

Novotech expands in Asia with new Malaysian base Novotech says its new “management hub” in Kuala Lumpur, Malaysia will serve as a base for expansion in the booming Asia-Pacific contract research sector. The contract research organisation (CRO), which already has operations in India and Korea, said that, in addition to Malaysia, the facility will manage [...]

BioTechnology News

Novotech expands presence in Asia Unlisted Australian contract research organisation Novotech is continuing its aggressive Asian expansion plans, announcing yesterday it will establish a regional management hub in Malaysia and a presence in Singapore, Thailand and the Philippines. Novotech, which has had a bumper year despite the economic downturn, according to chief executive Alek Safarian, [...]

Trials In Focus

New Asia hub for Novotech Australian-based CRO Novotech is expanding into four new Asian markets with the establishment of a management hub in Kuala Lumpur. The hub will cover Novotech’s presence in Singapore, Thailand and the Philippines, adding to a joint venture presence in India and an office in Korea. “A sizeable patient population, transparent [...]

Trials In Focus

Novotech kicks off Dimebon trial Recruiting has begun for local sites in a Phase III international multi-centre study of the new Pfizer/Medivation Alzheimer’s hope Dimebon (Latrepirdine). CRO Novotech Which is running the CONCERT trial in Australia is looking to recruit patients with mild to moderate Alzheimer’s disease (AD) over eight sites, three in NSW, two [...]

ABC 720 Morning show, (Perth)

Interviewing Dr Roger Clarnette, from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study. Broadcast: 03/09/2009. Host: Geoff Hutchinson. About this interview: Dr. Roger Clarenette from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study, trialing a new Alzheimer’s drug called [...]

ABC1 News

Alzheimer’s Disease Trial Broadcast: 03/09/2009 Host: Geoff Hutchinson About this interview: Dr. Roger Clarenette from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study, trialing a new Alzheimer’s drug called dimebon. Dr Roger Clarnette talks about the drugs origins, the results from the study so far as well [...]

BRW

Biotech Trials plummet The number of clinical trials conducted for Australian biotechnology companies, usually by contract research organisations (CRO), has fallen by about 32 percent in the past year. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1040

Pharma In Focus

Novotech’s success: Instant Update Sydney-based CRO, Novotech, is trumpeting its success despite the tight economic environment, announcing it attracted $22 million worth of new projects in the year to March. The company said it had been awarded 23 new multi-centre phase II and III clinical studies across a variety of therapeutic areas including oncology, ophthalmology, [...]

Next Page »